Jeffrey Gilligan, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 33 Hospital Ave., Danbury, CT 06810 Phone: 203-792-2003 Fax: 203-739-8926 |
Dr. Ramon A Batson, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Hospital Ave., Danbury, CT 06810 Phone: 203-792-2003 Fax: 203-739-8926 |
Dr. Joshua D Marcus, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Hospital Ave., Danbury, CT 06810 Phone: 203-792-2003 Fax: 203-739-8926 |
Scott P Sanderson, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Hospital Ave., Danbury, CT 06810 Phone: 203-792-2003 Fax: 203-739-8926 |
News Archive
Malaria parasites know good times from bad and plan their offspring accordingly, scientists have found, in a development that could inform new treatments.
L-3 Communications announced today that it has entered into an agreement to acquire Insight Technology Incorporated. Insight develops and manufactures mission critical night vision and electro-optical equipment including laser aiming and illumination devices, laser rangefinders, laser markers and designators, night vision goggles and monoculars, and thermal imaging systems.
Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.
The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.
In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
› Verified 3 days ago